Krsnaa Diagnostics · NSE: KRSNAA · BSE: 543328
Q3 FY22 results · Oct–Dec 2021
Krsnaa Diagnostics reported revenue from operations of ₹106.47 crore and net profit of ₹16.33 crore for Q3 FY22 (Oct–Dec 2021), on a consolidated basis.
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 106.47 | — | — | 108.26 | −1.7% |
| Other income | 4.34 | — | — | 3.23 | +34.3% |
| Total income | 110.81 | — | — | 111.49 | −0.6% |
| Profit before tax | 21.35 | — | — | 16.62 | +28.5% |
| Net profit for the period | 16.33 | — | — | 12.53 | +30.4% |
| EPS, basic (₹) | 5.67 | — | — | 4.51 | +25.7% |
| Net margin (%) | 15.3 | — | 11.6 |
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 106.31 | — | — | 108.26 | −1.8% |
| Other income | 4.34 | — | — | 3.23 | +34.3% |
| Total income | 110.65 | — | — | 111.49 | −0.8% |
| Profit before tax | 22.25 | — | — | 16.63 | +33.8% |
| Net profit for the period | 17.23 | — | — | 12.54 | +37.4% |
| EPS, basic (₹) | 5.97 | — | — | 4.51 | +32.4% |
| Net margin (%) | 16.2 | — | 11.6 |
Consolidated
- Filed with BSE
- 01 Feb 2022, 15:25 IST
- Board meeting
- 31 Jan 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 01 Feb 2022, 15:25 IST
- Board meeting
- 31 Jan 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE